Received Feb 23, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMRV | MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) | MERCK & CO. INC. | UNK | Z010731 | — |
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | UNK | Z008083 | — |
No additional AE; a patient was administered PROQUAD and VARIVAX concomitantly on 12/17/2025.; This Spontaneous report was received from Nurse and referred to a patient of unknown age and gender. The patient's medical history was not reported. The patient's past medications were not reported. The patient's concomitant medications were not reported. On 17-Dec-2025, the patient was vaccinated with Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live lyophilisate and solvent for solution for injection (1 dose, Lot Number: Z010731, Expiration date: 22-Dec-2026; strength, frequency and route were not reported) and Varicella Virus Vaccine Live (Oka-Merck) lyophilisate and solvent for solution for injection (1 dose, Batch/Lot Number: Z008083, Expiration date: 28-Apr-2027; strength, frequency and route were not reported) concomitantly for Prophylaxis (Overdose). No additional adverse event (AE)/no product quality complaints (PQC) reported.
DILUENT